March 11, 2014
For years, BEUC and many other organisations pressed for the transfer of responsibility for medicines from DG Enterprise to DG Sanco. It seemed wrong that one DG should combine responsibility for medicines with responsibility for promoting the European pharmaceutical industry. It was not, in my view, a question of impropriety but rather that it would be difficult for one DG to have a clear headed view of the two issues simultaneously. (I don’t know of any national government where the regulation of medicines is the responsibility of the industry rather than the health ministry.)
We got our wish at the beginning of the current Commission (Barosso II).
We had been often told that the Commission worked as a college and that it did not really matter which DG had which tasks. I think it did matter. I think there would not have been so much transparency on clinical trials […]